August 19, 2020 07:05 AM EDTUpdated 10:41 AM

Covid-19 roundup: Fauci, Collins intervene to stop FDA plasma authorization, citing weak data; Roche, Regeneron try to take antibodies global

Amber Tong

Max Gelman

Senior Editor

The FDA has placed on hold an emergency authorization for the use of plasma as a Covid-19 treatment following the intervention of top federal health …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Fauci, Collins intervene to stop FDA plasma authorization, citing weak data; Roche, Regeneron try to take antibodies global

Amber Tong

Max Gelman

Senior Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Viking's oral weight loss drug appears to have strong effect in Phase 1 trial

Is there room for MASH drugs in a GLP-1 world?

'We play to win': AstraZeneca details first results for oral GLP-1 and broader obesity ambitions

BioNTech says VEGF bispecific’s PD-L1 target, combo plans will be its edge

Novo adds to Wegovy’s cardio strength with hospital admissions analysis

Gene therapies don’t have to cost $4 million: New production platforms reduce development costs and risks

Covid-19 roundup: Fau­ci, Collins in­ter­vene to stop FDA plas­ma au­tho­riza­tion, cit­ing weak da­ta; Roche, Re­gen­eron try to take an­ti­bod­ies glob­al

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Covid-19 roundup: Fauci, Collins intervene to stop FDA plasma authorization, citing weak data; Roche, Regeneron try to take antibodies global